| Mrs Susanna Gregorzek, OTR/L | |
|
2 Dudley St, Suite 200, Providence, RI 02905-3236 | |
| (401) 457-1581 | |
| (401) 831-0500 |
| Full Name | Mrs Susanna Gregorzek |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 24 Years |
| Location | 2 Dudley St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760667380 | NPI | - | NPPES |
| 01152 | Other | RI | RI LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1045424 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Orthopedics Inc | 9931000395 | 156 |
News Archive
Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue. Therefore, current therapies essentially seek to destroy cancer cells to stop their proliferation. Through high-throughput genetic sequencing of glioblastoma cells, one of the most deadly brain tumors, a team of geneticists from the University of Geneva's (UNIGE) Faculty of Medicine discovered that some of these mutations are caused by supplemental extrachromosomal DNA fragments, called double minutes, which enable cancer cells to better adapt to their environment and therefore better resist to treatments meant to destroy them.
President Barack Obama is differentiating his positions from those of GOP challenger Mitt Romney, saying a Romney win could result in the overturning of Roe v. Wade. He is also assailing efforts to "redefine rape," attempting to link Romney to comments made by Indiana Republican Senate candidate Richard Mourdock.
New methods to examine the brain and spinal fluid heighten the chance of early diagnosis of Alzheimer's disease. Results from a large European study, led by researchers at the Karolinska Institutet, are now published in the medical journal BRAIN.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
| Provider Name | University Orthopedics Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235181041 PECOS PAC ID: 9931000395 Enrollment ID: O20040119000129 |
News Archive
Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue. Therefore, current therapies essentially seek to destroy cancer cells to stop their proliferation. Through high-throughput genetic sequencing of glioblastoma cells, one of the most deadly brain tumors, a team of geneticists from the University of Geneva's (UNIGE) Faculty of Medicine discovered that some of these mutations are caused by supplemental extrachromosomal DNA fragments, called double minutes, which enable cancer cells to better adapt to their environment and therefore better resist to treatments meant to destroy them.
President Barack Obama is differentiating his positions from those of GOP challenger Mitt Romney, saying a Romney win could result in the overturning of Roe v. Wade. He is also assailing efforts to "redefine rape," attempting to link Romney to comments made by Indiana Republican Senate candidate Richard Mourdock.
New methods to examine the brain and spinal fluid heighten the chance of early diagnosis of Alzheimer's disease. Results from a large European study, led by researchers at the Karolinska Institutet, are now published in the medical journal BRAIN.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Susanna Gregorzek, OTR/L 2 Dudley St, Suite 200, Providence, RI 02905-3236 Ph: (401) 457-1581 | Mrs Susanna Gregorzek, OTR/L 2 Dudley St, Suite 200, Providence, RI 02905-3236 Ph: (401) 457-1581 |
News Archive
Cancers are due to genetic aberrations in certain cells that gain the ability to divide indefinitely. This proliferation of sick cells generates tumors, which gradually invade healthy tissue. Therefore, current therapies essentially seek to destroy cancer cells to stop their proliferation. Through high-throughput genetic sequencing of glioblastoma cells, one of the most deadly brain tumors, a team of geneticists from the University of Geneva's (UNIGE) Faculty of Medicine discovered that some of these mutations are caused by supplemental extrachromosomal DNA fragments, called double minutes, which enable cancer cells to better adapt to their environment and therefore better resist to treatments meant to destroy them.
President Barack Obama is differentiating his positions from those of GOP challenger Mitt Romney, saying a Romney win could result in the overturning of Roe v. Wade. He is also assailing efforts to "redefine rape," attempting to link Romney to comments made by Indiana Republican Senate candidate Richard Mourdock.
New methods to examine the brain and spinal fluid heighten the chance of early diagnosis of Alzheimer's disease. Results from a large European study, led by researchers at the Karolinska Institutet, are now published in the medical journal BRAIN.
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia.
› Verified 4 days ago
Caitlin Kelly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Allison Marie Hourahan, OTR/L, CLT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 668 Eddy St, Providence, RI 02903 Phone: 401-274-1122 | |
Ms. Diana Navarro, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 353 Blackstone Blvd, Providence, RI 02906 Phone: 401-273-6565 | |
Mrs. Kelly L. Klampert, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9100 | |
Kristen Laurie Bourque, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Eddy St, Providence, RI 02905 Phone: 401-533-9165 Fax: 401-533-9105 | |
Miss Christa N Fadden, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-8661 | |
Miss Melissa Anne Barlow, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 401-793-5080 |